DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Aurionpro Solutions Limited — Outcome of Board Meeting

NSE 1 hr ago·31 Oct 2026, 2:38 pm

Aurionpro Solutions

Aurionpro Solutions has informed stock exchanges that its board has approved the financial results for the quarter and half year ending September 30, 2026. The company has submitted these reports to comply with regulatory disclosure norms.

This announcement is a routine corporate update that allows investors to track the company's performance against market expectations. For retail investors, it serves as a key data point to evaluate the firm's operational health and financial trajectory before the official release of the detailed financial statements.

Investors should watch for the official filing of the financial results to assess the company's revenue growth, margins, and cash flow. Monitoring the management commentary regarding future orders and sector trends will also be important for gauging the company's medium-term outlook.